SUBSCRIBE

Breaking News on Supplements & Nutrition - North AmericaEU edition

News > Research

Read more breaking news

 

 

Ayurvedic salacia herb shows pre-diabetes benefit: Study

1 commentBy Shane Starling , 18-Jun-2013
Last updated on 18-Jun-2013 at 14:01 GMT

An ayurvedic herb can manage pre-diabetes states and mild to moderate hyperlipidemia, according to Indian researchers.

For six weeks, 29 subjects received either a placebo and lifestyle therapy or 500mg of Salcital, a branded form of salacia reticulata root bark extract or leaves extract supplied by Indian firm Olive Lifesciences.

Only the Salcital root bark extract group registered a significant reduction in low-density lipoprotein cholesterol and fasting blood sugar (FBS) levels at week 3 and 6. The leaves extract group recorded a reduction only at week 6.

The researchers concluded: “Due to the presence of the a-glucosidase inhibitor ingredient in salacia, patients with prediabetes and mild to moderate hyperlipidemia exhibited improvements in serum lipid profiles and glycemic levels when treated with salacia extracts.”

The randomised, double-blind, placebo-controlled study was led by H.N. Shivaprasad from Olive Biosciences R&D department and was published this month in the Journal of Medicinal Food.

The randomised, double-blind, placebo-controlled study was led by H.N. Shivaprasad from Olive Biosciences R&D department and was published this month in the Journal of Medicinal Food.

Active ingredients of Salacia include salacinol, kotalanol, kotalagenin-16 acetate, and mangiferin.

“The active ingredients have a variety of actions, including postprandial glucose decrease by inhibiting a-glucosidases in the intestinal brush border, and thus slowing carbohydrate breakdown into absorbable monosaccharides,”  the researchers said, in describing potential mechanisms of action.

Pre-diabetes, also known as intermediate hyperglycemia, is a high-risk state for diabetes, with 5-10% of pre-diabetics moving to full diabetics each year.

Pre-diabetics can suffer from hyperlipidemia, hypertension, and insulin resistance-linked obesity.

Source:

Journal of Medicinal Food

June 2013, 16(6): 564-568

‘Salacia reticulata Improves Serum Lipid Profiles and Glycemic Control in Patients with Prediabetes and Mild to Moderate Hyperlipidemia'

Authors: H.N. Shivaprasad, M. Bhanumathy, G. Sushma, T. Midhun, K.R. Raveendra, K.R. Sushma, and K. Venkateshwarlu

1 comment (Comments are now closed)

Clinical efficacy of Salacia reticulata/ S.oblonga

The extract that is standardised to Salicinol and Kotanolol showed marked reduction of hyperglycaemia and it has similar action that of Acarbose. In Phytotech we are conducting a double blind clinical trial to justify this claim.

Report abuse

Posted by Venki Hariharan
22 June 2013 | 04h48

Related products